Tag

She said that the “good news” was in spite of the fact that more conclusive evidence was needed to ascertain the effectiveness of the new vaccine.

A new Ebola vaccine is being called “highly effective” following a small study in Guinea, West Africa.

Those involved in funding the trial called it a “remarkable” result and said the co-operation between organisations and countries that allowed it to come about augured well for future outbreaks of unsafe viruses.

“The “ring” vaccination method adopted for the vaccine trial is based on the smallpox eradication strategy”, John-Arne Røttingen, M.D., Ph.D., director of the division of infectious disease control at the Norwegian Institute of Public Health and chair of...

However, a vaccine has not been licensed yet, as it still remains experimental. And to be honest I wasn’t sure if I ever would have expected this to happen during my active (career) time. But in science, assumptions don’t count – data do.

As of right now, around 28,000 people in Guinea, Sierra Leone and Libera have been infected with Ebola, and more than 11,000 have died.

The British medical journal Lancet has published early test results and analyses of the findings.

WHO’s announcement said while the vaccine has shown 100 percent efficacy in individuals, “more conclusive evidence is needed on its capacity to protect populations through what is called ‘herd immunity.’ To that end, the Guinean national regulatory...

At this point no country would consider vaccinating all its children against Ebola, for example.